| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GASTROINTESTINAL CANCER |
1 Division of Diagnostic Radiology, Shizuoka Cancer Centre Hospital, Shizuoka, Japan
2 Division of Colorectal Surgery, Shizuoka Cancer Centre Hospital, Shizuoka, Japan
Correspondence to:
Correspondence to:
Dr H Furukawa
Division of Diagnostic Radiology, Shizuoka Cancer Centre Hospital, 1007, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan; h.furukawa{at}scchr.jp
ABSTRACT
Background: The role of positron emission tomography with the glucose analogue [18F] fluoro-2-deoxy-D-glucose (FDG-PET) in the initial staging of disease in patients with primary colorectal cancer (CRC) has not been adequately assessed.
Aims: To evaluate the additional value of FDG-PET as a staging modality, complementary to routine multidetector row computed tomography (MDCT) in patients with CRC.
Methods: Forty four patients with CRC underwent preoperative MDCT and FDG-PET. The accuracy of intraoperative macroscopic staging was also investigated compared with histopathological diagnosis. All FDG-PET images were evaluated with respect to detectability of the primary tumour, lymph node involvement, and distant metastases. Both MDCT and FDG-PET diagnoses and treatment plan were compared with surgical and histopathological results.
Results: Thirty seven patients underwent surgery. Tumour detection rate was 95% (42/44) for MDCT, 100% (44/44) for FDG-PET, and 100% (37/37) for intraoperative macroscopic diagnosis. Pathological diagnosis of T factor was T1 in five, T2 in four, T3 in 24, and T4 in four cases. Concordance rate with pathological findings of T factor was 57% (21/37) for MDCT and 62% (23/37) for macroscopic diagnosis. Lymph node involvement was pathologically positive in 19 cases. Regarding N factor, overall accuracy was 62% (23/37) for MDCT, 59% (22/37) for FDG-PET, and 70% (26/37) for macroscopic diagnosis. For all 44 patients, FDG-PET findings resulted in treatment changes in only one (2%) patient.
Conclusion: FDG-PET is not superior to routine MDCT in the initial staging of primary CRC.
Abbreviations: PET, positron emission tomography; FDG-PET, [18F] fluoro-2-deoxy-D-glucose-positron emission tomography; CRC, colorectal cancer; CT, computed tomography; MDCT, multidetector row computed tomography
Keywords: positron emission tomography; colorectal surgery; spiral computed tomography; colorectal neoplasms; neoplasm staging
Relevant Article
Gut 2006 55: 905.
This article has been cited by other articles:
|
|
 |
|
  C. S. R. Nahas, T. Akhurst, H. Yeung, E. Riedel, A. J. Markowitz, B. D. Minsky, P. B. Paty, M. R. Weiser, L. K. Temple, W. D. Wong, et al. Positron Emission Tomography Detection of Distant Metastatic or Synchronous Disease in Patients with Locally Advanced Rectal Cancer Receiving Preoperative Chemoradiation Ann. Surg. Oncol., March 1, 2008; 15(3): 704 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Herbertson, S. T. Lee, N. Tebbutt, and A. M. Scott The expanding role of PET technology in the management of patients with colorectal cancer Ann. Onc., November 1, 2007; 18(11): 1774 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Preoperative PET Scanning in Colorectal Cancer Isn't Useful Journal Watch Gastroenterology, August 4, 2006; 2006(804): 2 - 2. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
